Why is DNLI Down Today?
About Denali Therapeutics Inc. Common Stock
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates ...
Overall Confidence: 50%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector: 0.0%
Market Comparison
🔔 Get DNLI Alerts
We'll notify you when DNLI's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
DNLI has moved more than 3.0% down on 38 occasions in the past year.
Frequently Asked Questions
Why is DNLI stock down today?
DNLI is down 2.7% today on 0.6x average volume. The move appears to be driven by general market sentiment and momentum traders.
Is DNLI stock a buy or sell right now?
Based on current analysis, DNLI shows 50% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the DNLI stock price target?
DNLI is currently trading at $19.97. Based on today's momentum, the expected short-term range is $19.37 - $20.37. See long-term price prediction →
Will DNLI stock continue falling?
Our analysis shows a 45% probability that DNLI's move continues in the next 1-3 days. Key level to watch: $18.97 (support).
Is DNLI stock oversold or overbought?
DNLI's RSI (Relative Strength Index) is currently at 36.2. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.
What is the momentum for DNLI stock?
DNLI's 10-day momentum indicator is at 0.28. Positive momentum - the stock has mild upward pressure supporting the current trend.
Is DNLI outperforming or underperforming the market?
DNLI (-2.73%) is currently significantly underperforming the market (-3.5% vs SPY). Today, the S&P 500 (SPY) is up 0.74%, and Nasdaq (QQQ) is up 1.02%.
What does MACD indicate for DNLI?
DNLI's MACD (-0.75) is currently above the signal line (-0.84), indicating a bullish trend. This technical signal suggests buying pressure is dominant. The trend strength (ADX: 26.1) is strong.
Is DNLI in an uptrend or downtrend?
Based on moving average analysis, DNLI is in a bearish trend. The price ($19.97) is trading below both the 20-day SMA ($20.82) and 50-day SMA ($22.86). This alignment typically indicates sustained downward pressure.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis